as on February 6, 2026 at 3:04 pm IST
Day's Low
Day's High
2.82%
Downside
0.99%
Upside
52 Week's Low
52 Week's High
14.08%
Downside
69.72%
Upside
as on February 6, 2026 at 3:04 pm IST
Market Cap
₹146.48 Cr
Return on Equity (ROE)
11.45
PE Ratio (TTM)
7.8
Return on capital employed (ROCE)
14.96
Industry PE ratio
40.92
Beta (LTM)
1
P/B Ratio
1.2
Dividend Yield
0PEG Ratio
-7.5
Quarterly Earnings Growth YOY
-98.57
EPS (TTM)
9.27
Sector
Pharmaceuticals
Book Value
81.48
Technical Analysis
Bearish
View Technical Analysis
as on February 6, 2026 at 3:04 pm IST
Alpa Laboratories in the last 5 years
Lowest (7.03x)
January 21, 2026
Today (7.80x)
February 5, 2026
Industry (40.92x)
February 5, 2026
Highest (65.88x)
July 22, 2019
Today’s Price to Earnings Ratio: 7.80x
Compare market cap, revenue, PE, and other key metrics of Alpa Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 146.48 | 14.94% | 0.50 | 19 | 112 | |
| NA | 8.45 | -15.3% | 0.51 | -6 | 22 | |
| BUY | 17,127.68 | 1.21% | 0.58 | 170 | 1,694 | |
| NA | 2,278.53 | 16.07% | 0.53 | -9 | 559 | |
| NA | 61.08 | -11.1% | 0.00 | 1 | 33 |
Get share price movements and forecasts by analysts on Alpa Laboratories.
Source: S&P Global Market Intelligence
Search interest for Alpa Laboratories Ltd Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:67% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Alpa Laboratories.
Alpa Laboratories Ltd’s net profit fell -98.57% since last year same period to ₹0.11Cr in the Q2 2025-2026. On a quarterly growth basis, Alpa Laboratories Ltd has generated -99.07% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
![]()
Foreign Institutions have increased holdings from 0.35% to 0.36% in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 42.35% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.6% return, outperforming this stock by 151.6%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 57.29% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.8% return, outperforming this stock by 65.8%
Price Dip
![]()
In the last 6 months, ALPA stock has moved down by -28.6%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 11.77 Cr → 0.11 Cr (in ₹), with an average decrease of 99.1% per quarter
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 42.4 Cr → 29.32 Cr (in ₹), with an average decrease of 16.2% per quarter
| Organisation | Alpa Laboratories Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| CEO | Mahendra Singh Chawla |
| E-voting on shares | Click here to vote |
Alpa Laboratories share price today stands at ₹71 as on . Alpa Laboratories share today touched a day high of ₹71.7 and a low of ₹69.
Alpa Laboratories touched a 52 week high of ₹120.5 and a 52 week low of ₹61. Alpa Laboratories share price today i.e. is trending at ₹71, which is -41.08% down from its 52 week high and 16.39% up from its 52 week low.
Alpa Laboratories market capitalisation is ₹146.48 Cr as on .
To buy Alpa Laboratories shares, you need to follow these steps:
Alpa Laboratories trading volume is 8,440.00 as on . This means that 8,440.00 shares of Alpa Laboratories were bought and sold on the stock market during today's trading session.